Neutralizing anti-MIF antibodies, small molecules or endogenous inhibitors or MIF−/− mice have shown that MIF aggravates anti-GBM glomerulonephritis (69–71), experimental IgAN (79), and lupus nephritis (80). The gene discussed is MIF; the disease is glioblastoma.